TENAX THERAPEUTICS, INC. (TENX) Free cash flow 2016–2022
TENAX THERAPEUTICS, INC. (TENX) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$11.4MFY2022 · since FY2016: -$15.9M → -$11.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | -$11.4M | -4.9% |
| FY2021 | -$10.9M | -17.1% |
| FY2020 | -$9.3M | -22.7% |
| FY2019 | -$7.6M | -37.3% |
| FY2018 | -$5.5M | +54.7% |
| FY2017 | -$12.1M | +23.5% |
| FY2016 | -$15.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More TENX financial trends
TENX RevenueTENX Net incomeTENX Net marginTENX Gross profitTENX Gross marginTENX Operating incomeTENX Operating marginTENX Operating cash flowTENX Capital expendituresTENX Return on equityTENX Stock buybacksTENX Dividends paidTENX Total assetsTENX Total liabilitiesTENX Shareholders’ equityTENX overview →